Potential human teratogenicity of frequently prescribed drugs

Obstetrics and Gynecology

Volumn 75, Issue 4, 1990, Pages 594-599

  Friedman, J M ^a,b,c,d,e,f   Little, B B ^a,b,c,d,e,f   Brent, R L ^a,b,c,d,e,f   Cordero, J F ^a,b,c,d,e,f   Hanson, J W ^a,b,c,d,e,f   Shepard, T H ^a,b,c,d,e,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DOXYCYCLINE; NORETHISTERONE; PHENYTOIN; TETRACYCLINE; WARFARIN;

ADULT; ARTICLE; FEMALE; FETUS; GENETIC ENGINEERING; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TERATOGENICITY;

INFORMATION SYSTEMS; SUPPORT, U.S. GOV'T, P.H.S.; TERATOGENS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0025344243     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brent RL. The complexities of solving the problem of human malformations. Clin Perinatol 1986;24:491–503.
2. Tallarida RJ. MPD 85: Most-prescribed drugs 1985. Philadelphia: WB Saunders, 1986.
3. Physicians’ desk reference. 41st ed. Oradell, New Jersey: Medical Economics, 1987.
4. Shepard TH. Catalog of teratogenic agents. 6th ed. Baltimore: Johns Hopkins University Press, 1989.
5. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 2nd ed. Baltimore: Williams and Wilkins, 1986.
6. Schardein JL. Chemically induced birth defects. New York: Marcel Dekker, 1985.
7. Shepard TH. Human teratogenicity. Adv Pediatr 1986;33:225–68.
8. Brent RL. Evaluating the alleged teratogenicity of environmental agents. Clin Perinatol 1986;13:609–13.
9. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1973:143–7.
10. Toaff R, Ravid R. Tetracyclines and the teeth. Lancet 1966; ii:281–2.
11. Cohlan SQ. Tetracycline staining of teeth. Teratology 1977; 15:127–30.
12. Hanson JW, Myrianthopoulous NC, Harvey MAS, Smith DW. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976;89:662–8.
13. Nakane Y, Okuma T, Takahashi R, et al. Multiinstitutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan. Epilepsia 1980; 21:663–80.
14. Linhout D, Hoppener RJEA, Meinhari H. Teratogenicity of anti-epileptic drug combinations with special emphasis on the epoxidation (of carbamazepine). Epilepsia 1984;25:77–83.
15. Hiilesmaa VK, Teramo K, Granström ML, Bardy AH. Fetal head growth retardation associated with maternal epileptic drugs. Lancet 1981;ii:165–7.
16. Warkany J. Warfarin embryopathy. Teratology 1976;14:205–10.
17. Schardein JL. Congenital abnormalities and hormones during pregnancy: A clinical review. Teratology 1980;22:251–70.
18. Scialli AR. The Reprotox agent list. Reprod Toxicol 1987;1:81–8.